other material
confidence high
sentiment neutral
materiality 0.50
Theriva Biologics shareholders approve 2M share increase in stock plan, reelect directors at 2026 annual meeting
Theriva Biologics, Inc.
- Shareholders approved Amendment No. 4 to 2020 Stock Incentive Plan, increasing shares from 4.5M to 6.5M.
- All four director nominees elected: Kraws, Shallcross, Monahan, Wolf.
- Ratified BDO USA as independent auditor for FY2026.
- Approved charter amendment to increase authorized shares; Board has discretion to file.
- Approved issuance of common stock upon exercise of outstanding warrants.